Infectious Disease Therapeutics Market Revenue |CAGR of 3.8%

10 Oct 2024

Share :

Table of Content

1. Infectious Disease Therapeutics Market Revenue and Trends 2. Market Overview 3. Highlights of the Infectious Disease Therapeutics Market Report 4. Infectious Disease Therapeutics Market Trends 5. Regional Snapshot 6. Infectious Disease Therapeutics Market Highlights 7. Market News

Infectious Disease Therapeutics Market Revenue and Trends

The global infectious disease therapeutics market revenue reached USD 123.91 billion in 2023 and is predicted to attain around USD 173.33 billion by 2033, expanding at a CAGR of 3.8% during the forecast period. The demand for infectious disease therapeutics is increasing worldwide due to the rising prevalence of healthcare-associated infections (HAIs).

Market Overview

Diseases caused by infection due to pathogens are known as infectious diseases. Pathogens like viruses, parasites, bacteria, and fungi are considered under this category. These diseases can spread from one person to another by indirect or direct contact. Anti-infective drugs are effective for treating such conditions. Advancements in healthcare technology, including diagnosis and treatments, have contributed to infectious disease therapeutics market growth. These advancements have not only led to a reduction in the number of deaths due to early detection but also led to increased awareness among the people.

Highlights of the Infectious Disease Therapeutics Market Report

• Based on the mode of treatment, the drugs segment led the market with the largest share in 2023 due to the increasing demand for effective drugs among people. Drugs are considered cost-effective treatments and are easy to administer. The easy availability of drugs over the counter contributed to the segmental dominance.
• On the basis of target organism, the antibacterial segment accounted for the largest share of the market in 2023. This is primarily due to the increasing number of people suffering from infectious diseases that are caused by bacteria, which is propelling the demand for antibacterial drugs.
• Based on infection type, the bacterial infection segment held a large share of the market in 2023, owing to the tremendous growth in the number of people who suffer from such types of infections. Key market players are introducing and launching innovative drugs in the market to treat bacterial infections and reduce the burden of bacterial infections in a shorter period.
• On the basis of distribution channel, the hospitals segment dominated the market in 2023, capturing the largest share. Hospitals considered a primary care option due to the easy availability of advanced treatments and drugs. Moreover, reimbursement policies for hospital treatment encourage patients to get treatment from these settings.

Infectious Disease Therapeutics Market Trends

• Advancements in Medical Research and Technology: Recent medical research and technology advancements have revolutionized the infectious disease therapeutics market. It has led to several innovations in various areas, such as genomics and biotechnology. All these progresses are ultimately expected to boost the expansion of the infectious disease therapeutics market.
• Emergence of personalized medicine: With the growing number of patients with infectious diseases, the need for personalized medicine is rising. As their symptoms and the conditions vary, the demand for personalized medicines for each patient is at its peak. Prominent players have begun catering to the demands of patients by introducing specialized treatments for different patients.
• Shifting focus on combination therapies: Today, there is a strong shift toward combination therapies, which can intensify the efficiency of the treatments. Combination therapies can easily fight complex infectious diseases by lowering the chances of resistance.
• Technological advancements: Rising advancements in medical technology have led to various research activities that have further revolutionized the infectious disease therapeutics market. These advancements make diagnosis more effective than before, contributing to early diagnosis and prevention of disease.

Regional Snapshot

North America held the largest share of the infectious disease therapeutics market in 2023 due to the huge number of people belonging to the geriatric population. Elderly people are more prone to infectious diseases due to their lower immunity systems. Rapid modernization has taken place in this region, which has led to changes in lifestyle habits and unhealthy food habits that have greatly hampered the immunity systems of the people. This has emerged as a major factor in the growth of this region.

Asia Pacific is projected to be the fastest-growing region in the market. Governments of countries like India and China are focusing on disease prevention. The increasing number of patients suffering from infections contributes to the expansion of the market. Moreover, people have recognized the importance of early diagnosis due to the increasing prevalence of various infectious diseases.

Infectious Disease Therapeutics Market Highlights

Market News

• In August 2024, Red Queen Therapeutics, a biotechnology business company, introduced a $55M and tech to defeat elusive viral pathogens.
• In March 2024, Mirador Therapeutics, Inc., a next-generation pharmaceutical company, unveils $400M in funding to target immune-mediated inflammatory and fibrotic diseases.

Market Segmentation

By Mode of Treatment

• Vaccines
• Drugs

By Target Organism

• Antifungal
• Antiviral
• Antibacterial
• Anti-parasite
• Others

By Infection Type

• Viral
• Parasitic 
• Fungal
• Bacterial
• Others

By Distribution Channel

• Clinic
• Hospitals
• Others

Get this report to explore global market size, share, CAGR and trends, featuring detailed segmental analysis and an insightful competitive landscape overview@ https://www.precedenceresearch.com/checkout/2056

You can place an order or ask any questions, please feel free to contact at sales@precedenceresearch.com | +1 804 441 9344